The original article, published on 17 December 2019 in Polymer Bulletin volume 77, pages 6063 to 6083, reported the development and optimization of hydrogel networks built from pectin, a naturally occurring polysaccharide most familiar to consumers as the gelling agent in jams and jellies. In pharmaceutical science, pectin has attracted intense interest because it is biocompatible, biodegradable, inexpensive, and derived from renewable plant sources such as citrus peel and apple pomace. The research team, led by authors affiliated with Government College University Faisalabad, the University of Sargodha, The University of Lahore, and The Islamia University of Bahawalpur in Pakistan, set out to tune the swelling behavior, gel fraction, and drug release kinetics of these hydrogels so that nifedipine could be released steadily over an extended period rather than in a sudden burst.

Nifedipine is a calcium channel blocker widely prescribed for hypertension and angina, and its delivery profile matters enormously for patient safety. The drug is notoriously photolabile and poorly water soluble, and conventional immediate-release formulations have been associated with sharp drops in blood pressure and reflex tachycardia. Controlled-release matrices, including hydrogel systems, are designed to smooth out these peaks and troughs by allowing water to penetrate the polymer network, dissolve the drug, and then diffuse outward through the swollen mesh at a rate governed by crosslinking density, polymer composition, and mesh size. A pectin-based system with adjustable properties would, in principle, let formulators dial in the desired release rate simply by changing formulation variables, a proposition with genuine commercial and clinical appeal.

That is precisely why the concerns flagged by the Editor-in-Chief strike at the heart of the paper’s credibility. According to the expression of concern, Figure 5 of the pectin hydrogel article appears to be identical to Figure 2c in a separate 2018 publication on chondroitin sulfate-based hydrogels of loxoprofen, which appeared in Carbohydrate Polymers. The overlap involves two different polymers, two different drugs, and two different experimental contexts, making the apparent duplication particularly troubling. In materials characterization, figures typically present spectroscopic traces, swelling curves, or release profiles that are unique to a specific formulation under specific conditions. When the same figure surfaces in studies of unrelated polymer-drug combinations, it raises the possibility that the underlying experiments were not performed as described, or that images were reused to fill gaps in the data record.

The second concern is subtler but no less consequential. The Editor-in-Chief notes that the acrylic acid trace in Figure 2 of the pectin study appears highly similar to the trace in Figure 2 of yet another 2018 paper, this one describing a cross-linked sodium alginate-g-poly(acrylic acid) hydrogel network for the delivery of loxoprofen sodium, published in Advanced Polymer Technology. In that case, the similarity persists even though the x-axis appears to have been shifted slightly. Fourier transform infrared spectroscopy and related analytical traces are fingerprints of chemical structure, and while spectra of related acrylate-based networks can resemble one another, a near-duplicate trace with a minor axis shift suggests digital manipulation rather than independent measurement. Shifting an x-axis is a classic red flag in image-integrity investigations because it can make copied data look superficially distinct while preserving the underlying pattern.

Compounding these figure-level concerns is the authors’ response, or lack thereof. The expression of concern states that the authors have not provided the original scanning electron microscopy images, both before and after expansion, upon request. SEM micrographs are central evidence in hydrogel characterization, revealing pore morphology and network structure that correlate directly with swelling and diffusion behavior. When authors cannot or will not produce the raw image files underlying published micrographs, editors and readers lose the ability to verify that the images depict the samples in question. The notice also records that the authors have not responded to any correspondence from the editor or publisher regarding the expression of concern, leaving the issues unresolved and the scientific record in limbo.

Editorial Expressions of Concern occupy an important and often misunderstood niche in scholarly publishing. Unlike a retraction, which withdraws a paper’s findings from the literature, an expression of concern signals that doubts exist but that an investigation is incomplete, inconclusive, or ongoing. Journals typically issue them when institutional inquiries are pending, when authors are unresponsive, or when the evidence of problems is strong but not yet definitive. Readers are advised in this case to interpret the results with caution, which in practical terms means that researchers citing the paper should acknowledge its contested status and that clinicians or formulators should not rely on its reported optimization data without independent confirmation. The notice is linked to the original article through Crossmark, Springer Nature’s version-of-record update service, ensuring that anyone accessing the 2019 paper will see the alert.

The episode also shines a light on the broader challenge of image integrity in polymer and pharmaceutical sciences, fields that generate enormous volumes of spectroscopic traces, micrographs, and kinetic curves. Duplicate and manipulated figures have been documented across disciplines, and automated screening tools now routinely flag similarities that might once have escaped notice. The two earlier papers referenced in the expression of concern, both involving overlapping authorship with the pectin study, illustrate how concerns can cluster around related bodies of work. When a single figure or trace appears in multiple publications describing different chemical systems, the credibility of all affected papers comes into question, because at least some of the published data cannot reflect real experiments as described.

For the field of natural polymer drug delivery, the stakes extend beyond one paper. Pectin, alginate, chondroitin sulfate, and related polysaccharides remain genuinely promising scaffolds for controlled release, and well-executed studies continue to advance the area. But the credibility of that literature depends on the verifiability of individual results, and expressions of concern like this one serve as a reminder that optimization claims, release profiles, and structural characterizations must rest on data that can withstand scrutiny. Whether the 2019 pectin-nifedipine study is ultimately retracted, corrected, or exonerated, the case underscores a simple principle on which the entire enterprise of pharmaceutical materials science depends: the figures in a paper must be the honest record of the experiments the paper claims to describe.

Subject of Research: An Editorial Expression of Concern raised over a pectin-based hydrogel study for controlled nifedipine delivery in Polymer Bulletin

Article Title: Editorial Expression of Concern (EEoC): Pectin-based hydrogels with adjustable properties for controlled delivery of nifedipine: development and optimization

Article References: Editorial Expression of Concern (EEoC): Pectin-based hydrogels with adjustable properties for controlled delivery of nifedipine: development and optimization. (n.d.). https://doi.org/10.1007/s00289-026-06680-3

Image Credits: AI Generated

DOI: 10.1007/s00289-026-06680-3

Keywords: pectin hydrogels, nifedipine, controlled drug delivery, Editorial Expression of Concern, Polymer Bulletin, research integrity, image duplication, scanning electron microscopy, polysaccharide polymers, drug release kinetics, Springer Nature, pharmaceutics

The increasing interest in natural polysaccharides for drug delivery systems has opened up new research opportunities. Balangu seeds, rich in mucilage, present a promising option due to their biocompatibility and potential to improve the solubility of poorly water-soluble compounds like gallic acid. Gallic acid, a polyphenolic compound with numerous health benefits, is known for its antioxidant and anti-inflammatory properties. However, its therapeutic efficacy is often limited by its low solubility and rapid degradation. By encapsulating gallic acid within nanoparticles, researchers aim to enhance its delivery and prolong its action within the body.

The methodology employed in this study is particularly noteworthy. The ultrasonication-antisolvent method allows for the creation of nanoparticles at a molecular level, ensuring a uniform and controlled size distribution. This technique not only increases the efficiency of the encapsulation process but also enhances the stability of the nanoparticles, making them viable for various biomedical applications. The precise control offered by ultrasonication enables researchers to fine-tune the characteristics of the nanoparticles, including their size, morphology, and release profiles.

Throughout the experimental phase, the researchers meticulously examined the physicochemical properties of the fabricated nanoparticles. Techniques such as scanning electron microscopy and dynamic light scattering were utilized to assess the morphology and size distribution of the particles. The results demonstrated that the generated nanoparticles were spherical and had a size range suitable for optimal cellular uptake, which is crucial for effective drug delivery. These findings raise exciting possibilities for the use of Balangu seed mucilage nanoparticles in real-world applications, potentially paving the way for new formulations of dietary supplements and pharmaceuticals.

Moreover, the release kinetics of gallic acid from the nanoparticles were carefully evaluated. The study revealed that the encapsulated gallic acid exhibited a controlled release profile, which is a vital aspect in any drug delivery system. Controlled release mechanisms ensure that therapeutic agents are released over an extended period, maximizing their effectiveness while minimizing potential side effects. This feature of the nanoparticles makes them an attractive option for sustained therapeutic applications, thereby enhancing patient compliance and treatment outcomes.

The extensive characterization of Balangu seed mucilage nanoparticles also shed light on their interaction with biological media. Understanding how these nanoparticles behave in physiological conditions is critical for determining their potential in clinical applications. The researchers conducted stability and release studies in various simulated gastrointestinal media, and the findings indicated that the nanoparticles maintained their structural integrity, further supporting their prospect as effective carriers for oral drug delivery.

The biocompatibility of the nanoparticles is another critical factor that the researchers emphasized. Safety and toxicity assessments are essential steps in the development of any new drug delivery system. The study included cytotoxicity assays using human cell lines to evaluate the safety profile of the nanoparticles. The results demonstrated that the Balangu seed mucilage nanoparticles exhibited minimal cytotoxic effects, reinforcing their potential as a safe and effective delivery mechanism for bioactive compounds.

Beyond the immediate findings of this research, the broader implications are worth noting. The world is gradually shifting towards greener and more sustainable methods of production in pharmaceuticals and nutraceuticals. Utilizing natural polysaccharides derived from plants, such as Balangu seeds, aligns with this trend. It not only offers a renewable resource but also opens up opportunities for the development of eco-friendly drug delivery systems. The ability to create nanoparticles from natural materials could revolutionize manufacturing processes in the pharmaceutical industry, reducing reliance on synthetic polymers that often raise environmental concerns.

The study presented by Rostamabadi and Shekarchizadeh stands as a testament to the potential of harnessing nature’s resources for advanced biomedical applications. As researchers continue to explore the versatility of natural polymers, it is evident that the field is ripe for development. Future investigations may expand on the findings of this study by examining the encapsulation of other valuable compounds and the scalability of nanoparticle production methods.

In summary, the advent of Balangu seed mucilage nanoparticles represents a significant advancement in the field of drug delivery systems. Through innovative methodologies and comprehensive evaluations, the researchers have provided compelling evidence that supports the use of these nanoparticles for encapsulating gallic acid, thus enhancing its therapeutic potential. With continued research and development, this novel approach could lead to the creation of effective and sustainable delivery systems that align with the growing demand for natural products in healthcare.

As this research gains traction, it will likely encourage further studies into the applications of other natural polysaccharides in drug delivery systems. The integration of such green technologies in medicine not only promotes sustainability but also fosters innovations that could ultimately enhance healthcare outcomes around the globe. The future of drug delivery seems promising, with natural products taking center stage as both safe and effective alternatives to traditional methods.

The journey of Balangu seed mucilage nanoparticles from conception to practical application is just beginning. As the scientific community delves deeper into understanding these nanoparticles, the potential they hold for improving human health and well-being becomes increasingly evident. The next steps will involve clinical trials and real-world testing to validate their effectiveness and safety in diverse populations, showcasing the critical bridge between laboratory findings and practical solutions in medicine.

This transformative research not only exemplifies the ingenuity within the scientific community but also serves as an inspiration for future innovations. With each new finding, researchers are closer to developing solutions that not only solve immediate health challenges but also pave the way for a more sustainable and health-conscious future. The work of Rostamabadi and Shekarchizadeh is a pioneering endeavor that could set the precedent for a new era in drug delivery systems, putting natural products at the forefront of therapeutic advancements.

Subject of Research: Development of Balangu seed mucilage nanoparticles for encapsulation of gallic acid.

Article Title: Development of Balangu seed mucilage nanoparticles fabricated through ultrasonication-antisolvent method for encapsulation of gallic acid.

Article References:

Rostamabadi, M.M., Shekarchizadeh, H. Development of Balangu seed mucilage nanoparticles fabricated through ultrasonication-antisolvent method for encapsulation of gallic acid.
Sci Rep 15, 36922 (2025). https://doi.org/10.1038/s41598-025-20950-6

Image Credits: AI Generated

DOI:

Keywords: Balangu seed mucilage, nanoparticles, ultrasonication, gallic acid, drug delivery, biocompatibility, sustainable methods, natural polysaccharides.